Intervention Review

Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities

  1. Alex Thomson1,*,
  2. Stefanos Maltezos1,
  3. Elena Paliokosta1,
  4. Kiriakos Xenitidis2

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 12 MAY 2010

Assessed as up-to-date: 9 AUG 2007

DOI: 10.1002/14651858.CD007009.pub2

Database Title

Additional Information

How to Cite

Thomson A, Maltezos S, Paliokosta E, Xenitidis K. Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD007009. DOI: 10.1002/14651858.CD007009.pub2.

Author Information

  1. 1

    Kings College London, Institute of Psychiatry, Section of Brain Maturation (P050), London, UK

  2. 2

    Bethlem Royal Hospital, South London and Maudsley NHS Foundation Trust, Mental Impairment Evaluation and Treatment Services, Beckenham, Kent, UK

*Alex Thomson, Section of Brain Maturation (P050), Kings College London, Institute of Psychiatry, De Crespigny Park, London, SE5 8AF, UK. alex.thomson@kcl.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 12 MAY 2010

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (57K)Standard (296K)Full (296K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article (HTML) Summary (57K)Standard (296K)Full (296K)